Cargando…
Distinct plasma immune signatures in ME/CFS are present early in the course of illness
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is an unexplained incapacitating illness that may affect up to 4 million people in the United States alone. There are no validated laboratory tests for diagnosis or management despite global efforts to find biomarkers of disease. We conside...
Autores principales: | Hornig, Mady, Montoya, José G., Klimas, Nancy G., Levine, Susan, Felsenstein, Donna, Bateman, Lucinda, Peterson, Daniel L., Gottschalk, C. Gunnar, Schultz, Andrew F., Che, Xiaoyu, Eddy, Meredith L., Komaroff, Anthony L., Lipkin, W. Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465185/ https://www.ncbi.nlm.nih.gov/pubmed/26079000 http://dx.doi.org/10.1126/sciadv.1400121 |
Ejemplares similares
-
Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS
por: Milivojevic, Milica, et al.
Publicado: (2020) -
Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS
por: Guo, Cheng, et al.
Publicado: (2023) -
Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome
por: Nagy-Szakal, Dorottya, et al.
Publicado: (2017) -
ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature
por: Komaroff, Anthony L., et al.
Publicado: (2023) -
Natural killer cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a multi-site clinical assessment of ME/CFS (MCAM) sub-study
por: Querec, Troy D., et al.
Publicado: (2023)